Matthew D. Ringel, MD (he/him/his)

Professor and Chair
The Ohio State University
Columbus, OH, United States

Dr. Ringel is Professor and founding Chair of the Department of Molecular Medicine and Therapeutics at The Ohio State University where he holds the Ralph W. Kurtz Endowed Chair. He also is the Deputy Director for Basic Research of the OSU Comprehensive Cancer Center and Founding director and current co-director of the Center of Cancer Engineering. Dr. Ringel’s laboratory has defined signaling pathways that regulate thyroid cancer progression and therapeutic resistance and has identified predisposing genes for thyroid cancer. He maintains an active clinical practice focused on thyroid cancer. He is an elected member of the American Society of Clinical Investigation (ASCI) and the American Association of Physicians (AAP) and has been awarded the Van Meter and Sidney Ingbar Awards from the American Thyroid Association (ATA) as well as the NCI Director’s service award from NIH. Among his many leadership roles in societies, me most recently served as co-Chair and co-first author of the 2025 ATA Thyroid Cancer Guidelines.

Disclosure information not submitted.

Presentation(s):

• YI01-03 - Year in Thyroid

  Sunday, June 14, 2026
  4:30 PM - 6:00 PM CT

• MON-319 - Rarα Functions as A Lineage Stabilizer in Breast Cancer Are Disrupted by the Corepressor PRAME

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT